TG Therapeutics Inc (TGTX) — Cash Flow Quality Index
TG Therapeutics Inc (TGTX) has a Cash Flow Quality Index of -0.06x as of September 2025. Operating cash flow of $-23.15 Million is below net income of $390.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of TG Therapeutics Inc to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
TG Therapeutics Inc Cash Flow Quality Index (2010–2024)
Historical Cash Flow Quality Index for TG Therapeutics Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check TG Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for TG Therapeutics Inc (2010–2024)
Year-by-year earnings quality comparison for TG Therapeutics Inc. For live market cap and the full company financial profile, see how much is TG Therapeutics Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.73x | $-40.52 Million | $23.38 Million | ▲ +30.1% |
| 2023 | -2.48x | $-31.41 Million | $12.67 Million | ▲ +21.5% |
| 2010 | -3.16x | $-1.97 Million | $623.64K | — |